These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21376242)

  • 1. Horizons in therapy for corneal angiogenesis.
    Maddula S; Davis DK; Maddula S; Burrow MK; Ambati BK
    Ophthalmology; 2011 Mar; 118(3):591-9. PubMed ID: 21376242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneal neovascularization: updates on pathophysiology, investigations & management.
    Sharif Z; Sharif W
    Rom J Ophthalmol; 2019; 63(1):15-22. PubMed ID: 31198893
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammatory corneal neovascularization: etiopathogenesis.
    Clements JL; Dana R
    Semin Ophthalmol; 2011; 26(4-5):235-45. PubMed ID: 21958169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatments for corneal neovascularization: a review.
    Gupta D; Illingworth C
    Cornea; 2011 Aug; 30(8):927-38. PubMed ID: 21389854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).
    Azar DT
    Trans Am Ophthalmol Soc; 2006; 104():264-302. PubMed ID: 17471348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-based antiangiogenic applications for corneal neovascularization.
    Liu S; Romano V; Steger B; Kaye SB; Hamill KJ; Willoughby CE
    Surv Ophthalmol; 2018; 63(2):193-213. PubMed ID: 29080632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corneal neovascularization and biological therapy.
    Voiculescu OB; Voinea LM; Alexandrescu C
    J Med Life; 2015; 8(4):444-8. PubMed ID: 26664467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases.
    Bock F; Maruyama K; Regenfuss B; Hos D; Steven P; Heindl LM; Cursiefen C
    Prog Retin Eye Res; 2013 May; 34():89-124. PubMed ID: 23348581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization.
    Lai CM; Brankov M; Zaknich T; Lai YK; Shen WY; Constable IJ; Kovesdi I; Rakoczy PE
    Hum Gene Ther; 2001 Jul; 12(10):1299-310. PubMed ID: 11440623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limbal stem cell deficiency and corneal neovascularization.
    Lim P; Fuchsluger TA; Jurkunas UV
    Semin Ophthalmol; 2009; 24(3):139-48. PubMed ID: 19437349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current treatments for corneal neovascularization].
    Benayoun Y; Petellat F; Leclerc O; Dost L; Dallaudière B; Reddy C; Robert PY; Salomon JL
    J Fr Ophtalmol; 2015 Dec; 38(10):996-1008. PubMed ID: 26522890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal angiogenic privilege and its failure.
    Di Zazzo A; Gaudenzi D; Yin J; Coassin M; Fernandes M; Dana R; Bonini S
    Exp Eye Res; 2021 Mar; 204():108457. PubMed ID: 33493471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiogenesis and lymphangiogenesis in the cornea. Pathogenesis, clinical implications and treatment options].
    Cursiefen C; Seitz B; Dana MR; Streilein JW
    Ophthalmologe; 2003 Apr; 100(4):292-9. PubMed ID: 12682761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune privilege and angiogenic privilege of the cornea.
    Cursiefen C
    Chem Immunol Allergy; 2007; 92():50-57. PubMed ID: 17264482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of corneal neovascularization prior to corneal transplantation: Report of 112 cases].
    Belghmaidi S; Hajji I; Ennassiri W; Benhaddou R; Baha Ali T; Moutaouakil A
    J Fr Ophtalmol; 2016 Jun; 39(6):515-20. PubMed ID: 27324233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging therapies for corneal neovascularization.
    Roshandel D; Eslani M; Baradaran-Rafii A; Cheung AY; Kurji K; Jabbehdari S; Maiz A; Jalali S; Djalilian AR; Holland EJ
    Ocul Surf; 2018 Oct; 16(4):398-414. PubMed ID: 29908870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current methods of anti-angiogenic influence on newly formed corneal vessels].
    Vestn Oftalmol; 2013; 129(3):98-101. PubMed ID: 23879033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of corneal neovascularization and modern options for its suppression].
    Mamikonyan VR; Pivin EA; Krakhmaleva DA
    Vestn Oftalmol; 2016; 132(4):81-87. PubMed ID: 28635927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs.
    Koenig Y; Bock F; Kruse FE; Stock K; Cursiefen C
    Cornea; 2012 Aug; 31(8):887-92. PubMed ID: 22362005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Treatments for Corneal Angiogenesis.
    Syed ZA; Dana R
    Int Ophthalmol Clin; 2017; 57(4):31-38. PubMed ID: 28885245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.